ODD
Oddity Tech Ltd.
Set alert
- YTD
- -46.07%
- 1 year
- -50.21%
- Open
- 21.76
- Prev close
- 21.69
- Mkt cap
- 999.52M
- Vol
- 652.65K
- Avg vol
- 1.09M
- EPS
- 0.22
- P/E
- 98.50
- Div yield
- 0.00%
More statistics
- Low
- 20.90
- High
- 22.00
- Forward P/E
- 19.06
- Beta
- 2.24
- Short ratio
- 3.91
- Inst. own
- 110.67%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 18.38
- 200-d avg
- 17.58
- 1y target
- 16.06
Key statistics
- Market cap
- 999.52M
- Enterprise value
- 1.40B
- Trailing P/E
- 98.50
- Forward P/E
- 19.06
- PEG ratio
- 0.00
- Price / sales
- 1.47
- Price / book
- 4.25
- EPS (TTM)
- 0.22
- Beta
- 2.24
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 2.23%
- Revenue (TTM)
- 679.08M
- Revenue growth
- -25.10%
- Free cash flow
- -64.76M
- Total cash
- 193.15M
- Total debt
- 559.24M
- Return on equity
- 5.10%
- Shares outstanding
- 34.58M
- Short % of float
- 19.64%
- 50-day average
- 18.38
- 200-day average
- 17.58
Analyst view
Consensus: hold
- Target (low)
- 9.00
- Target (mean)
- 16.06
- Target (high)
- 22.00
- Strong buy0
- Buy0
- Hold8
- Sell1
- Strong sell2
Next earnings
Nov 11, 2026
Expected Nov 11, 2026. Consensus EPS estimate 0.30006.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2026 | Sep 30, 2026 | 0.30 | — | — | — |
| Sep 9, 2026 | Jun 30, 2026 | 0.1223 | 0.20 | +0.08 | +63.53% |
| Jun 2, 2026 | Mar 31, 2026 | -0.04 | -0.17 | -0.13 | -325.00% |
| Feb 25, 2026 | Dec 31, 2025 | 0.14 | 0.20 | +0.06 | +42.86% |
| Nov 19, 2025 | Sep 30, 2025 | 0.3214 | 0.40 | +0.08 | +24.46% |
| Aug 4, 2025 | Jun 30, 2025 | 0.839 | 0.87 | +0.03 | +3.69% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 15, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Sep 10, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Sep 10, 2026 | Truist Securities | main | Hold | Hold |
| Sep 10, 2026 | Evercore ISI Group | main | In-Line | In-Line |
| Sep 9, 2026 | Jefferies | main | Hold | Hold |
| Sep 8, 2026 | Needham | reit | Hold | Hold |
About Oddity Tech Ltd.
Oddity Tech Ltd. operates as a consumer tech company that builds digital-first brands for the beauty and wellness industries in the United States, Israel, and internationally. It serves consumers through its platform, which uses data science, machine learning, and computer vision capabilities to identify consumer needs, and develop solutions in the form of beauty, wellness, and technology products. The company provides a portfolio of products, including face and complexion, eye, brow and lip products, makeup tools, bodycare, medical grade prescription and OTC products, skincare, color cosmetics, haircare, and supplements under the IL MAKIAGE and SpoiledChild brands. In addition, it operates ODDITY LABS, a biotechnology center, which deploys AI-based molecule discovery technology to identify and launch novel ingredients that delivers performance and outcomes for consumers in beauty and wellness. Oddity Tech Ltd. was incorporated in 2013 and is headquartered in Jaffa, Israel.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- Israel
- Website
- oddity.com
News
- New Strong Buy Stocks for October 29th
- ODDITY to Announce Third Quarter 2026 Financial Results on November 11, 2026
- Baillie Gifford Trims ODDITY Tech Ltd (ODD) Stake -- Shares Look 55% Undervalued on GF Value
- Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
- ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026
- Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
- Oddity Tech (ODD) Upgraded to Strong Buy: Here's What You Should Know
- New Strong Buy Stocks for October 15th
- Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition
- ODDITY Tech Ltd (ODD) Shares Fall 5.1% -- What GF Score of 71 Tells Investors
Your note
Sign in to keep a note on ODD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DRUCKER MANN LINDSAY | Chief Financial Officer | Conversion of Exercise of derivative security | Sep 29, 2026 | 127,848 |
| NIR YEHOSHUA | Director | Conversion of Exercise of derivative security | Jul 27, 2026 | 8,645 |
| PAYORSKI LILACH CPA | Director | Conversion of Exercise of derivative security | Jul 27, 2026 | 15,513 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| BAILLIE GIFFORD & CO | 22.37% | 7,735,080 | 167.62M | Jun 29, 2026 |
| Morgan Stanley | 15.70% | 5,428,020 | 117.63M | Jun 29, 2026 |
| Catterton Management Company, L.L.C. | 10.23% | 3,537,472 | 76.66M | Sep 29, 2026 |
| Blackrock Inc. | 10.11% | 3,496,556 | 75.77M | Jun 29, 2026 |
| Frontier Capital Management Company LLC | 5.32% | 1,838,400 | 39.84M | Jun 29, 2026 |
| MSD Partners, L.P. | 5.15% | 1,781,661 | 38.61M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD WORLD FUND-Vanguard U.S. Growth Fund | 5.15% | 1,780,553 | 38.58M | May 30, 2026 |
| Brighthouse Funds Trust I-Morgan Stanley Discovery Portfolio | 3.29% | 1,138,876 | 24.68M | Jun 29, 2026 |
| MORGAN STANLEY INSTITUTIONAL FUND TRUST-Discovery Portfolio | 2.19% | 756,691 | 16.40M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.82% | 629,275 | 13.64M | Sep 29, 2026 |
| MORGAN STANLEY INSTITUTIONAL FUND INC-Inception Portfolio | 1.32% | 455,249 | 9.87M | Jun 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 1.32% | 454,876 | 9.86M | Aug 30, 2026 |